Publications
57 publications
Funding
10 grants
Active
1 grant- Sub-PILongitudinal Follow up of Clinical Trial Participants For Brain DonationNational Institute on Aging · 2023–2028 · via University of Southern CaliforniaU24AG057437-06
Completed grants (9)
- Sub-PIBrain DonationNational Institute on Aging · 2022–2024 · via University of Southern CaliforniaR01AG061848-03
- Sub-PIA4-OLE - Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension StudyNational Institute on Aging · 2019–2023 · via University of Southern CaliforniaR01AG063689-03
- Sub-PITau PET Imaging for the USC Alzheimer's Therapeutic Research Institute (USC ATRI) A4 Trial (“A4 TAU”)Foundation for the National Institutes of Health, Inc. · 2015–2023 · via University of Southern CaliforniaUSC 16101659-03
- Sub-PIMetformin in Alzheimer’s dementia Prevention (MAP)National Institute on Aging · 2019–2021 · via Columbia UniversityR01AG062624-02
- Co-IUnderstanding the dynamic interactions between tau pathology and microglia-mediated inflammation in Alzheimer's DiseaseNational Institute on Aging · 2019–2021R56AG064873-01
- Sub-PIAlzheimer’s Disease Cooperative Study – A4 StudyNational Institute on Aging · 2015–2020 · via University of Southern CaliforniaU19AG010483-26
- Sub-PIEffects of Traumatic Brain Injury and Post-Traumatic Stress Disorder on Alzheimer's Disease (AD) in Veterans With Mild Cognitive Impairment (MC) Using the Alzheimer's Disease Neuroimaging InitiativeU.S. Department of Defense · 2015–2019 · via University of Southern CaliforniaWEI1808-1916 EWOF
- Sub-PIADNI-DOD: Effects of Traumatic Brain Injury and Posttraumatic Stress Disorder On Alzheimer's Disease in Veterans Using ADNIU.S. Department of Defense · 2015–2019 · via University of Southern CaliforniaWEI1808-1915
- Sub-PIEffects of Traumatic Brain Injury and Post-Traumatic Stress Disorder and Alzheimer's Disease on Brain Tau in Vietnam Veterans Using ADNIU.S. Department of Defense · 2015–2018 · via University of Southern CaliforniaWEI1872-06
Clinical research
1 study
Completed & closed trials (1)
- PINCT04241068Phase 3b Open-Label, Multicenter, Safety Study of BIIB037 (Aducanumab) in Subjects With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205PHASE3 · Biogen, Inc. · IRB STUDY CLOSURE (as of 2025)Alzheimer's Disease